Search research articles
Contact Us
Filters
Showing results (71-80 of 287) with videos related to
Page
of 29
Sort By:
The International Journal of Biological Markers
|
November 24, 1999
Blood concentrations of tumor necrosis factor-alpha in malignant lymphomas and their decrease as a predictor of disease control in response to low-dose subcutaneous immunotherapy with interleukin-2
P Lissoni, S Bolis, M Mandalà, et al.
The International Journal of Biological Markers
|
July 7, 2000
Changes in circulating dendritic cells and IL-12 in relation to the angiogenic factor VEGF during IL-2 immunotherapy of metastatic renal cell cancer
A Bonfanti, P Lissoni, R Bucovec, et al.
Tumori
|
April 30, 1989
Malignant testicular germ cell tumor in father and son: a case report
S Crispino, G Lombardi, G Bratina, et al.
Recenti Progressi in Medicina
|
August 6, 1998
[Pharmacokinetics of melatonin]
P Lissoni, F Rovelli, G Fumagalli, et al.
The International Journal of Biological Markers
|
July 1, 1997
Increased blood concentrations of interleukin-12 are associated with a longer survival in untreatable metastatic solid tumor patients: preliminary observations
P Lissoni, F Rovelli, L Fumagalli, et al.
Tumori
|
December 31, 1990
Evaluation of the cardiovascular toxicity related to cancer immunotherapy with interleukin-2 by monitoring atrial natriuretic peptide secretion: a case report
P Lissoni, S Barni, G Cattaneo, et al.
Oncology
|
July 1, 1996
Preoperative interleukin-2 subcutaneous immunotherapy may prolong the survival time in advanced colorectal cancer patients
F Brivio, P Lissoni, G Alderi, et al.
Tumori
|
January 1, 1995
Second-line therapy with interferon-alpha plus vinblastine in metastatic renal cell cancer patients progressed under interleukin-2 subcutaneous immunotherapy
F Paolorossi, S Villa, S Barni, et al.
Tumori
|
June 30, 1994
Ondansetron does not stimulate prolactin release in breast cancer patients
P Lissoni, M Cazzaniga, F Rovelli, et al.
Neuro Endocrinology Letters
|
May 4, 2001
Anti-angiogenic activity of melatonin in advanced cancer patients
P Lissoni, F Rovelli, F Malugani, et al.
Page
of 29
Search research articles
Search
Showing results (71-80 of 287) with videos related to
Sort By:
Page
of 29
The International Journal of Biological Markers
|
November 24, 1999
Blood concentrations of tumor necrosis factor-alpha in malignant lymphomas and their decrease as a predictor of disease control in response to low-dose subcutaneous immunotherapy with interleukin-2
P Lissoni, S Bolis, M Mandalà, et al.
The International Journal of Biological Markers
|
July 7, 2000
Changes in circulating dendritic cells and IL-12 in relation to the angiogenic factor VEGF during IL-2 immunotherapy of metastatic renal cell cancer
A Bonfanti, P Lissoni, R Bucovec, et al.
Tumori
|
April 30, 1989
Malignant testicular germ cell tumor in father and son: a case report
S Crispino, G Lombardi, G Bratina, et al.
Recenti Progressi in Medicina
|
August 6, 1998
[Pharmacokinetics of melatonin]
P Lissoni, F Rovelli, G Fumagalli, et al.
The International Journal of Biological Markers
|
July 1, 1997
Increased blood concentrations of interleukin-12 are associated with a longer survival in untreatable metastatic solid tumor patients: preliminary observations
P Lissoni, F Rovelli, L Fumagalli, et al.
Tumori
|
December 31, 1990
Evaluation of the cardiovascular toxicity related to cancer immunotherapy with interleukin-2 by monitoring atrial natriuretic peptide secretion: a case report
P Lissoni, S Barni, G Cattaneo, et al.
Oncology
|
July 1, 1996
Preoperative interleukin-2 subcutaneous immunotherapy may prolong the survival time in advanced colorectal cancer patients
F Brivio, P Lissoni, G Alderi, et al.
Tumori
|
January 1, 1995
Second-line therapy with interferon-alpha plus vinblastine in metastatic renal cell cancer patients progressed under interleukin-2 subcutaneous immunotherapy
F Paolorossi, S Villa, S Barni, et al.
Tumori
|
June 30, 1994
Ondansetron does not stimulate prolactin release in breast cancer patients
P Lissoni, M Cazzaniga, F Rovelli, et al.
Neuro Endocrinology Letters
|
May 4, 2001
Anti-angiogenic activity of melatonin in advanced cancer patients
P Lissoni, F Rovelli, F Malugani, et al.
Page
of 29